Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Athula, Abeyratne"'
Publikováno v:
European Heart Journal. 40
Background Given the significance of hypertension (HTN) as a major risk factor for cardiovascular disease, stroke, HF, and mortality, uncontrolled HTN remains a large public health problem. Pacemaker patients are well trapped in the healthcare system
Autor:
Stephen R. Shorofsky, George Monir, J. Russell Bailey, Paul A. Friedman, Kishlay Anand, Ulrika Birgersdotter-Green, Athula Abeyratne, Linda L. Ruetz, Henry H. Hsia
Publikováno v:
Circulation: Arrhythmia and Electrophysiology. 5:1073-1080
Background— Implantable cardioverter-defibrillator system efficacy is tested at implant by induction of ventricular fibrillation (VF). Defibrillation safety margin can be assessed without VF induction using upper limit of vulnerability methods, but
Autor:
B S Elise Higgins, Paul A. Friedman, Giovanni Rovaris, Mark L. Brown, Abhishek Deshmukh, Athula Abeyratne, Brian W. Schousek
Publikováno v:
Pacing and clinical electrophysiology : PACE. 39(10)
Background Patients with implantable cardioverter defibrillators (ICDs) often have a history of atrial fibrillation (AF) or will develop AF after device implant. Optimal management of ICD patients includes early diagnosis of AF and monitoring of AF b
Publikováno v:
Heart Rhythm. 8:1889-1894
Background Prediction of sustained ventricular tachycardia (VT)/ventricular fibrillation (VF) could help to guide preventive interventions in at-risk patients. The QRST integral (∫QT) reflects intrinsic repolarization properties. Objective The obje
Autor:
Mithilesh K. Das, Anne M. Gillis, Xiaohong Zhou, Charles D. Swerdlow, Athula Abeyratne, Raja N. Ghanem, Theodore Chow
Publikováno v:
Circulation. 123:1052-1060
Background— T-wave alternans (TWA) increases before ventricular tachycardia (VT) or fibrillation (VF), suggesting that it may warn of VT/VF in implantable cardioverter-defibrillator patients. Recently, we described a method for measuring alternans
Autor:
Kevin T. Ousdigian, Kenneth A. Ellenbogen, Athula Abeyratne, Bruce D. Gunderson, Haresh Sachanandani, Charles D. Swerdlow
Publikováno v:
Circulation. 122:1449-1455
Background— Downloadable software upgrades are common in consumer electronics but not in implantable medical devices. Fractures of implantable cardioverter-defibrillator (ICD) leads present commonly as inappropriate shocks. A lead-integrity alert (
Publikováno v:
Heart Rhythm. 5:670-676
T-wave alternans (TWA) increases acutely prior to ventricular tachycardia (VT) or fibrillation (VF) in animal studies, suggesting that it may provide a warning for VT/VF in implantable cardioverter defibrillator (ICD) patients. Clinically, measuremen
Publikováno v:
2015 First International Conference on Reliability Systems Engineering (ICRSE).
High product quality and reliability are critical in the medical device industry. Accurate reliability prediction during the product development stage provides inputs for the design strategy and boosts understanding and confidence in product reliabil
Autor:
Keith K. Holloman, Jeanne Leffler, Dave Verness, Tim Vaughn, Mark A. Wood, Richard K. Shepard, Marlene T. Dow, Athula Abeyratne, Kenneth A. Ellenbogen, Henry F. Clemo
Publikováno v:
Journal of the American College of Cardiology. 41(1):73-80
Objectives This study evaluated the long-term reliability of an implantable cardioverter defibrillator (ICD) lead to determine the incidence, clinical presentation, and management of lead failure. Background Despite recent advances in ICD technology,
Autor:
Kazutaka Aonuma, John Gorcsan, David O. Martin, Randall C. Starling, Maurizio Gasparini, Athula Abeyratne, Kathy Lai-Fun Lee, Goran Milasinovic, David H. Birnie, Henry Krum, Alex Sambelashvili, Mahmoud Houmsse, Bernd Lemke
Publikováno v:
Heart rhythm. 10(9)
Acute studies have suggested that left ventricular pacing (LVP) may have benefits over biventricular pacing (BVP). The adaptive cardiac resynchronization therapy (aCRT) algorithm provides LVP synchronized to produce fusion with the intrinsic activati